Overview

Retrospective Evaluation of Combination Treatment With the Ulthera System

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
A retrospective study to evaluate the Ulthera® System for its potential interaction with toxins and fillers. Up to 500 subjects will be enrolled.
Details
Lead Sponsor:
Ulthera, Inc
Treatments:
Hyaluronic Acid
incobotulinumtoxinA